Congenital hereditary endothelial dystrophy caused by SLC4A11 mutations progresses to Harboyan syndrome

Salina Siddiqui1, Juan Carlos Zenteno, Aine Rice

  • 1*Section of Ophthalmology and Neuroscience, Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, United Kingdom; †Department of Ophthalmology, St James's University Hospital, Leeds, United Kingdom; ‡Department of Biochemistry, Faculty of Medicine, National Autonomous University of Mexico (UNAM), Mexico City, Mexico; §Department of Genetics, Institute of Ophthalmology "Conde de Valenciana," Mexico City, Mexico; and ¶Department of Ophthalmology, Bradford Royal Infirmary, Bradford, United Kingdom.

Cornea
|December 20, 2013
PubMed

Insights

Congenital hereditary endothelial dystrophy (CHED) patients with SLC4A11 mutations often develop sensorineural hearing loss, progressing to Harboyan syndrome. Monitoring CHED patients for hearing loss is recommended.

Area of Science:

  • Genetics
  • Ophthalmology
  • Audiology

Background:

  • Mutations in SLC4A11 cause rare genetic disorders affecting the cornea and hearing.
  • Congenital hereditary endothelial dystrophy (CHED) and Harboyan syndrome are linked to homozygous SLC4A11 mutations.
  • Fuchs endothelial corneal dystrophy (FECD) is associated with dominant SLC4A11 mutations.

Purpose of the Study:

  • Investigate hearing loss progression in CHED patients.
  • Assess carrier parents of CHED patients for signs of FECD.
  • Analyze the role of SLC4A11 mutations in disease manifestation.

Main Methods:

  • Genetic screening for SLC4A11 mutations in CHED patients.
  • Audiometric testing to evaluate hearing function.
  • Clinical examination and specular microscopy for patients and parents.

Main Results:

  • SLC4A11 mutations confirmed in 4 CHED patients from 3 families.
  • All patients exhibited sensorineural hearing loss, particularly at higher frequencies.
  • Two carrier parents showed guttate lesions, suggesting potential FECD risk.

Conclusions:

  • CHED with homozygous SLC4A11 mutations can progress to Harboyan syndrome with variable severity.
  • CHED patients require monitoring for progressive hearing loss.
  • Further research is needed to confirm FECD risk in carrier parents.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
110
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.2K
Genetic Lingo01:11

Genetic Lingo

Overview
84.7K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
906